Assignee
SOLVAY PHARM BV
NL·57 granted patents·23 pending applications·325 citations·filing 2000–2011
Top patents by PatentIndex Score
80 records- 0192US6476060B24,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2001·Granted Nov 5, 2002·78 cites·24 claims
- 0287US6974810B24,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activitySOLVAY PHARM BV·Filed 2002·Granted Dec 13, 2005·31 cites·9 claims
- 0386US7728018B2Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antagonistsSOLVAY PHARM BV·Filed 2007·Granted Jun 1, 2010·11 cites·11 claims
- 0486US7524867B2Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivitySOLVAY PHARM BV·Filed 2005·Granted Apr 28, 2009·10 cites·11 claims
- 0585US7923026B2Embedded micellar nanoparticlesSOLVAY PHARM BV·Filed 2007·Granted Apr 12, 2011·26 cites·22 claims
- 0684US7964604B2Bifeprunox mesylate maintenance dose compositions and methods for using the sameSOLVAY PHARM BV·Filed 2007·Granted Jun 21, 2011·10 cites·34 claims
- 0782US7528162B24,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2002·Granted May 5, 2009·20 cites·16 claims
- 0882US7189525B2Human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2006·Granted Mar 13, 2007·5 cites·3 claims
- 0981US7109216B21H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activitySOLVAY PHARM BV·Filed 2004·Granted Sep 19, 2006·14 cites·13 claims
- 1079US7786126B2Combination preparations comprising SLV308 and a dopamine agonistSOLVAY PHARM BV·Filed 2007·Granted Aug 31, 2010·1 cites·19 claims
- 1179US7319110B21H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activitySOLVAY PHARM BV·Filed 2003·Granted Jan 15, 2008·14 cites·4 claims
- 1278US6828325B2PhenylpiperazinesSOLVAY PHARM BV·Filed 2002·Granted Dec 7, 2004·13 cites·5 claims
- 1376US7786144B2Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonistsSOLVAY PHARM BV·Filed 2007·Granted Aug 31, 2010·2 cites·13 claims
- 1476US7608718B24,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activitySOLVAY PHARM BV·Filed 2005·Granted Oct 27, 2009·2 cites·2 claims
- 1576US7371737B22-substituted-6-trifluoromethyl purine derivatives with adenosine-A3 antagonistic activitySOLVAY PHARM BV·Filed 2005·Granted May 13, 2008·4 cites·15 claims
- 1675US7964728B2Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibitionSOLVAY PHARM BV·Filed 2007·Granted Jun 21, 2011·2 cites·7 claims
- 1773US6958396B28-{4-[3-(5-fluoro-1H-indol-3-YL)-Propyl]-Piperazin-1-YL}-2-methyl-4H-Benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine D2 receptor and the serotonin reuptake siteSOLVAY PHARM BV·Filed 2002·Granted Oct 25, 2005·7 cites·6 claims
- 1872US7709024B2Sustained-release formulation and uses thereofSOLVAY PHARM BV·Filed 2006·Granted May 4, 2010·1 cites·9 claims
- 1971US7307079B21,3,5-Triazine derivatives as ligands for human adenosine-A3 receptorsSOLVAY PHARM BV·Filed 2003·Granted Dec 11, 2007·9 cites·14 claims
- 2071US6911448B2Piperazine and piperidine compoundsSOLVAY PHARM BV·Filed 2001·Granted Jun 28, 2005·5 cites·10 claims
- 2170US7776860B2Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereofSOLVAY PHARM BV·Filed 2005·Granted Aug 17, 2010·1 cites·6 claims
- 2270US7678789B2[1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particularSOLVAY PHARM BV·Filed 2006·Granted Mar 16, 2010·1 cites·6 claims
- 2370US7371769B2Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sitesSOLVAY PHARM BV·Filed 2005·Granted May 13, 2008·1 cites·18 claims
- 2470US7186741B2Neurotensin active 2,3,diaryl-pyrazolidine derivativesSOLVAY PHARM BV·Filed 2003·Granted Mar 6, 2007·6 cites·4 claims
- 2569US7405216B2Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)SOLVAY PHARM BV·Filed 2004·Granted Jul 29, 2008·4 cites·25 claims
- 2669US7244734B2Hexa- and octahydro-pyrido[1,2-a]pyrazine derivatives with NK1 antagonistic activitySOLVAY PHARM BV·Filed 2004·Granted Jul 17, 2007·6 cites·8 claims
- 2769US6855532B2Human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2002·Granted Feb 15, 2005·3 cites·22 claims
- 2868US7851630B2Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptorsSOLVAY PHARM BV·Filed 2004·Granted Dec 14, 2010·4 cites·6 claims
- 2967US7067513B1PhenylpiperazinesSOLVAY PHARM BV·Filed 2000·Granted Jun 27, 2006·3 cites·7 claims
- 3065US7750013B2N-oxides as prodrugs of piperazine and piperidine derivativesSOLVAY PHARM BV·Filed 2006·Granted Jul 6, 2010·1 cites·8 claims
- 3163US7202238B2Diazabicyclo alkane derivatives with NK1 antagonistic activitySOLVAY PHARM BV·Filed 2003·Granted Apr 10, 2007·4 cites·6 claims
- 3262US7605162B2PhenylpiperazineSOLVAY PHARM BV·Filed 2008·Granted Oct 20, 2009·0 cites·6 claims
- 3360US7495108B2Imidazoline derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2007·Granted Feb 24, 2009·0 cites·5 claims
- 3460US7312321B2Antibody to human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2007·Granted Dec 25, 2007·0 cites·2 claims
- 3560US6998398B2Solid salts of benzazepine compounds and pharmaceutical compositions containing themSOLVAY PHARM BV·Filed 2004·Granted Feb 14, 2006·3 cites·15 claims
- 3660US2008070259A1Novel Human Enzymes of the Metalloprotease FamilySOLVAY PHARM BV·Filed 2007·Application pending·0 cites
- 3759US7524853B2Compounds and their use in therapySOLVAY PHARM BV·Filed 2004·Granted Apr 28, 2009·1 cites·40 claims
- 3858US7928134B25-aryl-4,5-dihydro-(1H)-pyrazolines as cannabinoid CB1 receptor agonistsSOLVAY PHARM BV·Filed 2008·Granted Apr 19, 2011·0 cites·11 claims
- 3958US2010010062A1Method of treatment using eprosartanSOLVAY PHARM BV·Filed 2009·Application pending·0 cites
- 4057US7083965B2Human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2004·Granted Aug 1, 2006·0 cites·6 claims
- 4157US7015333B2Process for preparation of imidazolyl compoundsSOLVAY PHARM BV·Filed 2003·Granted Mar 21, 2006·2 cites·10 claims
- 4256US8034379B2Ion-strength independent sustained release pharmaceutical formulationSOLVAY PHARM BV·Filed 2001·Granted Oct 11, 2011·2 cites·34 claims
- 4356US7915262B2Combination preparations comprising SLV308 and a dopamine agonistSOLVAY PHARM BV·Filed 2010·Granted Mar 29, 2011·0 cites·2 claims
- 4455USD589606SPharmaceutical tabletSOLVAY PHARM BV·Filed 2008·Granted Mar 31, 2009·15 cites·1 claims
- 4555US7498348B21 H-imidazole derivatives as cannabinoid receptor modulatorsSOLVAY PHARM BV·Filed 2007·Granted Mar 3, 2009·0 cites·3 claims
- 4655US7173044B2Imidazoline derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2005·Granted Feb 6, 2007·0 cites·7 claims
- 4754US7595310B2Glucuronate salt of a piperazine compoundSOLVAY PHARM BV·Filed 2006·Granted Sep 29, 2009·0 cites·25 claims
- 4854US6998255B1Human G-protein coupled receptorSOLVAY PHARM BV·Filed 2000·Granted Feb 14, 2006·2 cites·41 claims
- 4953US7696383B2N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugsSOLVAY PHARM BV·Filed 2008·Granted Apr 13, 2010·0 cites·11 claims
- 5053US7615551B2Salicylate and gentisate salts of a piperazine compoundSOLVAY PHARM BV·Filed 2006·Granted Nov 10, 2009·0 cites·25 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SOLVAY PHARM BV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →